Intervacc is trading 5.3% down today at €0.09, tracking a 3% decline in the biotech sector amid broader risk-off sentiment in growth stocks.
- The move follows a week of steady declines and elevated volatility, which is characteristic of unprofitable biotech equities.
- No fresh company-specific news or catalysts have been reported, suggesting the price action is driven by macro factors rather than internal developments at Intervacc.